Search Results
Displaying 181 - 190 of 1091
… we celebrate the most mysterious and fascinating organ in the body—the brain—by participating in Brain Awareness Week , March 11-17. … and our interactive Brain “Lobe-oratorium” to highlight what each brain lobe does for perception, thinking, …
… The primary objective for developing preclinical common data … a well-defined lexicon for describing and reporting how preclinical data are collected with the goal of enhancing rigor, reproducibility and transparency in study performance. The goal of CDEs is to develop a tool …
… (OGHHD) at the National Institute of Neurological Disorders and Stroke, National Institutes of Health ( NIH ). … address health disparities and inequities in neurological disorders. … …
… neuroscience research. The K01 application should present a complete, consistent, and compelling story of how the … skills you will need as an independent researcher. What techniques will your lab use to investigate your area of … apply for funding in a few years? Build a career plan that is tailored to your needs. What activities will you perform …
… to all studies. Nevertheless, attention to principles of good study design and reporting transparency are essential to … NIH application instructions . The purpose of this list is to explicitly identify elements of rigorous and … Plans to report sample size and effect size, along with a valid measure of uncertainty, for all relevant experiments …
… and implementing quality assurance (QA) procedures that can be integrated into their clinical research projects. The … document contains the Guidelines and Bibliography . It can be used for multi-center study clinical research … an approved, common protocol to assure that data collected can be aggregated for analysis and interpretation. Key …
- The NINDS has a responsibility to ensure that mechanisms and procedures are in place to protect the safety of participants in NINDS-supported clinical trials. Therefore, prior to subject accrual, the Awardee will provide the following for review and approval by the NINDS:
- The detailed plan for data and safety monitoring (see Section B below)
- The clinical research protocol, including details of study design, proposed interventions, patient eligibility and exclusion criteria, plans for the…
It is a fundamental ethical principal that all medical research should involve the consent of the subject. Sometimes, however, the subject cannot consent because of the severity of their condition. In order to improve the care of patients with severe head injury, for example, or those who are seizing or having a stroke, subjects must be enrolled in clinical trials, but of course they are unable to give a timely consent, and their health proxy may not be available.
In certain situations, the Food and Drug Administration allows some…